secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001493152-25-006419
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell regains Nasdaq minimum bid price compliance; delisting risk resolved
-----------------------------------------------------------------------------

- Received Nasdaq notice of compliance with $1.00 minimum bid price requirement on Feb 12, 2025.
- Deficiency letter previously received on August 22, 2024; now resolved.
- Matter is closed; company continues listing on Nasdaq Capital Market.
- Common shares (BCTX) and warrants (BCTXW) remain eligible for trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225006419/0001493152-25-006419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225006419/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer